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Abstract
Background: Secretory leucocyte protease inhibitor (SLPI) is an anti-inflammatory protein that is constitutively
expressed in multiple cell types where it functions to counteract localized tissue inflammation by its anti-
inflammatory, antimicrobial and anti-protease properties. Little is known about the expression and implication of
SLPI in the regulation of adipose tissue inflammation. Therefore, we tested the hypothesis that obesity induces
expression of SLPI in adipose tissue where it functions to counteract adipocyte inflammation.
Methods: Male C57BL6 mice were fed a high fat (60% fat calories) or a control diet (10% fat calories) diet for
12 weeks. Adipose tissue expression of SLPI was determined by western blotting and PCR. Fully differentiated
adipocytes (3T3-L1) were treated with lipopolysaccharide (LPS, 100 ng/ml) or peptidoglycan (10 μg/ml) for
24 hours in the presence or absence of SLPI. Media was collected for interleukin 6 (IL-6) analysis by enzyme-linked
immune absorbent assay (ELISA). RNA was isolated for gene expression analysis by real-time polymerase chain
reaction (RT-PCR).
Results: Visceral fat (mesenteric and epididymal) express a higher level of SLPI than subcutaneous fat. The
expression of SLPI is mostly in the stromal vascular fraction compared to adipocytes. We also confirmed in vitro
that activation of TLR2 and 4 with peptidoglycan and LPS respectively leads to induction of SLPI. Finally, we
confirmed that SLPI exerted an anti-inflammatory effect in adipocytes treated with LPS by causing a reduction in
expression of IL-6 via a mechanism that included stabilization of cellular IKBa expression.
Conclusion: Our results show that SLPI is also expressed in adipocytes and adipose tissue where it could play an
important feedback role in the resolution of inflammation.
Background
Obesity is associated with adipose tissue inflammation
that eventually results in insulin resistance. This is char-
acterized by adipose tissue macrophage infiltration [1,2],
elevated expression of inflammatory cytokines, including
TNFa [3], IL6 [4], monocyte chemoattractant protein
(MCP) 1 [5], plasminogen activator inhibitor (PAI) 1[6].
Inflammatory cytokines produced in adipose tissue act
locally and systemically to amplify the inflammatory cas-
cade and oppose insulin signaling in peripheral tissues.
However, little is known about mechanisms that lead to
resolution of inflammation in adipose tissue. Secretory
leucocyte protease inhibitor (SLPI) is a protein that may
play a major role in the dampening of inflammation in
adipose tissue. It is an 11.7-kD non-glycosylated protein
produced primarily at mucosal surfaces, especially in the
upper respiratory tract [7]. In the lung [8], SLPI inter-
acts and inhibits the activity of several proteolytic
enzymes, making it an integral component of the
defense mechanism in the lung. Apart from its anti-
protease activity, SLPI also exerts anti-inflammatory
effect against viral and antibacterial targets [9]. SLPI
also inhibits NF-B activation and production of TNF-a
and nitric oxide [10] and SLPI knockout mice have an
exaggerated inflammatory response and go into septic
shock after LPS administration [11]. Although SLPI is
expressed at multiple tissues during inflammation where
it acts to counter the inflammatory events, there is no
report of adipose tissue expression of SLPI or a potential
anti-inflammatory role of SLPI in adipocytes. Therefore,
we examined its expression in adipose tissue of mice
that have been fed a high fat diet and in 3T3-L1
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tors (TLR) 2 and 4, two major inflammatory receptors
in adipose tissue [12,13 ].
We demonstrate herein, for the first time, that SLPI is
upregulated in adipose tissue in obesity. Additionally, we
show that SLPI opposes induction of IL6 by LPS in adi-
pocytes. Therefore, SLPI could be a potential target for
the regulation of inflammation in adipose tissue.
Methods
3T3-L1 Adipocyte Culture
Cells were obtained from ATCC (Manassas, VA) and cul-
tured according to standard conditions. Briefly, cells were
g r o w nu n d e r5 %C O 2i nD u l b e c c o ’s Modified Eagles
Medium (DMEM) containing 10% fetal bovine serum
(Hyclone, Logan, UT) and 0.5% penicillin-streptomycin
mixture (Invitrogen, Carlsbad, CA). Cells were allowed to
reach confluence, and two days post confluence (day 0),
were induced to differentiate with a medium containing
10% fetal bovine serum, 1.7 μMi n s u l i n ,1μMd e x a -
methasone, and 0.5 mM IBMX for 48 h. Thereafter, fresh
medium containing only insulin and fetal bovine serum
was added for another 2 days. From then on media was
replenished every 2 days with DMEM containing only
10% FBS. Fully differentiated cells were treated for
24 hours with either Staphylococcus aureus derived pepti-
doglycan (10 μg/mL) or E.coli lipopolysaccharride
(100 ng/mL) (Sigma, St. Louis. MO).
Animals
Eight week old male C57BL/6J mice were fed either a
high fat diet (HF, D12492i) with 60% fat calories (n = 8)
or a control diet (LF, D12450Bi) with 10% calories (n =
8) from fat (Research Diets, New Brunswick, NJ, http://
www.researchdiets.com) for 12 weeks. At the end of the
experiment animals were euthanized by CO2 asphyxia-
tion followed by cervical dislocation. All animal care
protocols were approved by the Purdue Animal Care
and Use Committee. Epididymal adipose tissue was
obtained by careful dissection of adipose tissue around
the epididymis and used for RNA extraction with Trizol
(Invitrogen, Carlsbad, CA) or tissue lysates for western
blotting. We also collected subcutaneous (collected from
underneath the skin around the lumbar area), mesen-
teric (collected by careful dissection of adipose tissue
from around the intestine) for a comparative analysis of
SLPI mRNA expression by real-time PCR. To determine
the relative expression of SLPI in adipocytes and stromal
vascular fraction (SVF), adipose tissue was subjected to
collagenase digestion (1 mg/ml Collagenase type 1,
Sigma) in Krebs Ringer Buffer (118.5 mM NaCl,
4.8 mM KCl, 2.7 mM CaCl2,1 . 2m MK H 2PO4,1 . 1m M
MgSO4,7 H2O, 25 mM NaHCO3,5m Mg l u c o s ea n d
5% (w/v) BSA, pH 7.4) with shaking at 150 RPM for
30 minutes at 37°C. After digestion, adipocytes were
allowed to separate by flotation and the infranatant
solution was centrifuged for 5 minutes at 300 g to pellet
the stromovascular fraction (SVF). The adipocyte frac-
tion was washed three times with the KRB buffer to
remove contaminants and ensure a pure population of
adipocytes. This method has been validated with flow
cytometry to yield a 100% pure population of adipocytes.
Subsequently, RNA was isolated from adipocytes and
the SVF for comparison with whole adipose tissue.
Anti-inflammatory effect of SLPI
Differentiated 3T3-L1 adipocytes were pretreated for
2 hours with 10 ng/ml recombinant human SLPI (R &D
Systems, Minneapolis, MN) and then treated with LPS
for 3 hours. Media was recovered for ELISA and RNA
for RT-PCR.
Real-time quantitative RT-PCR
Total RNA from treated cells was extracted with Trizol
Reagent (Invitrogen) according to the manufacturer’s
protocol. The mRNAs were treated with Turbo DNase
(Ambion, Austin, TX) to remove contaminating DNA
and reverse transcribed into cDNA using Improm II
reverse transcriptase (Promega, Madison, WI). Real-time
PCR was performed using a MyIQ real-time PCR detec-
tion machine (Bio-Rad) with the Faststart SYBR green
based mix (Roche, Indianapolis, IN). Primers sequences
used were: IL-6, 5’-AACGATGATGCACTTGCAGA-3’
and 5’-GAGCATTGGAAATTGGGGTA-3’ for the sense
and antisense primers, respectively (14); SLPI, sense,
5’-TGCTTAACCCTCCCAATGTC-3’ and antisense,
5’-AA TGCTGAGCCAAAAGGAGA-3’; b-actin sense,
5’-AT GGGTCAGAAGGACTCCTACG-3’ and anti-
sense, 5’-AGTGGTACGACCAGAGGCATAC-3’;T N F a,
5’-AG CCCCCAGTCTGTATCCTT-3’ and 5’-CTCC
CTT TGCAGAACTCAGG-3’. Quantification of tran-
scripts was done with the ΔΔ Ct method with normali-
zation against the b-actin.
Immunoblotting
Whole tissue lysates were obtained by homogenizing tis-
sues and cells in RIPA lysis buffer (0.5 M Tris-HCl,
1.5 M HCl, 2.5% Deoxycholic acid, 10% NP-40 and
10 mM EDTA) supplemented with protease and phos-
phates inhibitor cocktail (Sigma). Homogenized tissues
and cells were then cleared of cellular and tissue debris
by centrifugation at 10,000 g for 10 minutes at 4°C. Pro-
tein concentrations were determined with the BCA kit
(Sigma). For immunoblotting, 50 μg of lysates were
resolved on a 10% SDS-PAGE gel and transferred to a
nitrocellulose membrane. Membranes were probed with
rabbit anti-SLPI (Cat # SC-28803, Santa Cruz, CA,
USA) primary antibody and HRP-conjugated anti-rabbit
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MA, USA). To determine the role of IKBa protein in
the regulation of SLPI effect, the expression of phos-
phorylated and native IKBa was quantified by western
blotting using rabbit primary antibodies (Cat# 2859 and
4812, Cell Signaling, Danvers, MA, USA). Blots were
subsequently blotted with the Supersignal
® West Pico
chemilumniscent reagent (Pierce, Rockford, IL) and
exposed to autoradiographic film to capture protein spe-
cific signals.
ELISA for Media IL-6
Media concentration of IL-6 was determined with a
mouse IL-6 ELISA kit (Endogen, Rockford, IL) accord-
ing to the manufacturer’s instructions. This kit has an
assay sensitivity of < 7 pg/ml and an inter assay and
intra assay variation of < 10%.
Statistical analyses
All data were checked for normality and then analyzed
using the GLM model analysis. When treatment effects
were significant, mean separation was accomplished
using the least-squares mean separation procedure.
Results
Adipose tissue expression of SLPI and regulation by high
fat diet
First, we determined the expression of SLPI in adipose tis-
sue after a high fat (HF) diet. Increased protein and
mRNA expression of SLPI was observed in epididymal fat
from mice on high fat diet compared to mice on control
(LF) diet (Figure 1A and 1B) (P < 0.05). Next, to determine
if there are differences in SLPI expression in different adi-
pose depots, we examined SLPI expression in subcuta-
neous, epididymal and mesenteric depots (Figure 1C).
Highest expression of SLPI expression was found in adi-
pose tissue from the mesenteric depot (P < 0.05) than the
epididymal and subcutaneous depots. Additionally, signifi-
cantly higher expression was found in the stromal vascular
fraction than adipocytes (Figure 1D), an indication that
this fraction is responsible for most of the increase in SLPI
expression in adipose tissue in high fat diet. The higher
expression SLPI in visceral depots (mesenteric and epidi-
dymal) than subcutaneous depot agrees with the higher
level of TNFa, a classic marker of inflammation, observed
in the epididymal tissue of mice on high fat diet, visceral
(mesenteric and subcutaneous) vs. subcutaneous depot
and in stromal vascular cells vs. adipocytes and whole adi-
pose tissue (Figures 2A, B and 2C).
Regulation of SLPI expression in adipocytes by
inflammatory stimuli and anti-inflammatory effect of SLPI
Adipocytes express both TLR2 and TLR4 and the
expression of these receptors is upregulated in obesity.
Figure 1 High fat feeding increases SLPI expression in adipose
tissue of mice. Mice were fed either a control low fat (LF) or high
fat (HF) diet for 12 weeks. Epididymal adipose tissue were obtained
and subjected to western blotting for SLPI protein. A representative
blot is presented in Figure 1A. Expression of SLPI mRNA was
quantified in Figures 1B, 1C and 1D. High fat feeding increases SLPI
mRNA (Figure 1B) in adipose tissue. Higher expression of SLPI was
observed in epididymal and mesenteric depots compared to the
subcutaneous depot (Figure 1C), and in the stromal vascular faction
compared to adipocytes (Figure 1D). Bars represent means and ±
SEM. Superscript letters represent significant mean differences,
P < 0.05.
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cytes with peptidoglycan and LPS, ligands for TLR2 and
TLR4, could alter the expression of SLPI. Both peptido-
glycan and LPS (Figures 3A and 3B) upregulated expres-
sion of SLPI (P < 0.05), suggesting that activation of
these receptors in vivo could play a major part in the
regulation of SLPI in adipose tissue. To determine
whether SLPI exerts an anti-inflammatory role in
adipocytes, 3T3-L1 adipocytes were pretreated for
2 hours with SLPI (10 ng/ml) and then with LPS
(100 ng/ml) for 24 hours. Pretreatment of adipocytes
with SLPI (Figures 4A and 4B) suppressed IL6 mRNA
expression and protein secretion (P < 0.05). Therefore,
SLPI may be an important protein that is induced in
adipose tissue during obesity to dampen the inflamma-
tory tone.
SLPI stabilized IKBa expression in LPS treated adipocytes
Due to the importance of IKBa as a negative regulator
of TLR signaling, we investigated the effect of SLPI on
Figure 2 High fat feeding increases Inflammation in adipose
tissue of mice. Mice were fed either a low fat (LF) or high fat (HF)
diet for 12 weeks. Epididymal adipose tissue was obtained and
subjected RT-PCR for expression of TNFa. High fat feeding increased
TNFa mRNA (Figure 2A) in adipose tissue. Higher expression of
TNFa was observed in epididymal and mesenteric depots
compared to the subcutaneous depot (Figure 2B), and in the
stromal vascular faction compared to adipocytes (Figure 2C). Bars
represent means and ± SEM. Superscript letters represent significant
mean differences, P < 0.05.
Figure 3 Regulation of SLPI expression by LPS and
peptidoglycan. Differentiated 3T3-L1 adipocytes were either
untreated (control, C) or treated with 100 ngml lipopolysaccharide
(LPS) or peptidoglycan (PEP) (10 μg/ml) for 24 hours. SLPI mRNA
was determined by RT-PCR and western blotting. Both LPS and
peptidoglycan increased SLPI mRNA (Figure 3A) and protein (Figure
3B). Bars represent means and ± SEM of 4 different replicates.
Superscript letters represent significant mean differences, P < 0.05.
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resulted in significant stabilization of IKBa (Figures 5A
and 5B), suggesting that stabilization of IKBa remains a
possible mechanism by which SLPI counteracts inflam-
mation in adipocytes.
Discussion
Inflammation plays a major role in obesity-induced insu-
lin resistance by the release of multiple inflammatory
cytokines that oppose insulin signaling [14]. Although
the endogenous mechanisms that trigger adipose tissue
inflammation are not very clear, there is evidence that
innate pattern recognition receptors such as TLR2 and 4
play key roles in this process [12,13]. These innate
immune receptors are highly expressed in adipocytes and
many functional assays have shown that their activation
evokes inflammatory responses that are accompanied by
increased expression of many inflammatory mediators
(IL6, TNFa, MCP-1) [15,16]. However, mechanisms that
lead to resolution of inflammation in adipose tissue are
less well studied; despite the well established paradigm
that initiation of inflammatory response is often accom-
panied by concurrent activation of feedback mechanisms
that act to suppress inflammatory response [17-19].
In support of the presence of this mechanism in adipo-
cytes, activation of NFB and MAPK pathways in adipo-
cytes by LPS is transient and rapidly returns to basal over
time [20]. Although several mechanisms are behind the
feedback mechanism of inflammation resolution [17-19],
SLPI is recognized as a potent anti-inflammatory protein
that is induced to suppress tissue inflammation [21].
Therefore, the increase in SLPI expression in adipose tis-
sue in diet-induced obesity suggests that SLPI may play a
role to antagonize inflammation in adipose tissue. The
higher expression of SLPI in the stromal vascular fraction
correlates well with the elevated expression of TNFa.
This suggests that SLPI expression is induced in propor-
tion to the degree of inflammation and agrees with a role
for SLPI in dampening the inflammatory state. It also
indicates that immune cells such as macrophages, which
make up the bulk of the stromal vascular fraction may be
the major source of adipose tissue SLPI. Therefore, coun-
ter-regulatory mechanisms exist in adipose tissue to sup-
press inflammation and SLPI may be part of these
mechanisms. Although SLPI is highly expressed in muco-
sal surfaces [22,23], detection of its expression in adipose
Figure 4 Anti-inflammatory effects of SLPI in adipocytes.
Adipocytes were pretreated with 10 ng/ml recombinant SLPI for
2 hours and then treated with LPS (100 ng/ml) for 24 hours.
Pretreatment with SLPI attenuates induction of IL6 mRNA (Figure
4A) and protein (Figure 4B). Bars represent means and ± SEM of
4 different replicates. Superscript letters represent significant mean
differences, P < 0.05.
Figure 5 SLPI stabilizes IKB a expression level. Adipocytes were
pretreated with 10 or 100 ng/ml recombinant SLPI for 2 hours and
then treated with LPS (100 ng/ml) for 24 hours. Cell lysates were
analyzed for the expression of phospho-IKB a and IKB a.
Pretreatment with SLPI prevents the reduction of IKB a by LPS
treatment (Figures 5A and B.) Bars represent means and ± SEM of 4
different replicates. Superscript letters represent significant mean
differences, P < 0.05.
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tion of inflammation in adipose tissue as well. Indeed,
pretreatment of adipocytes with SLPI leads to downregu-
lation of LPS induced IL-6 gene expression and protein
secretion, confirming a functional role for SLPI in inflam-
mation resolution in adipocytes. The anti-inflammatory
action of SLPI may involve stabilization of IKBa abun-
dance. Activation of TLR2 and 4 increased expression of
SLPI in macrophages [10,24] and in adipocytes as con-
firmed in this study. Therefore, because TLR2 and TLR4
are activated in adipose tissue in obesity [12,13], the
induction of SLPI in adipose tissue during obesity may be
influenced by the activation state of the TLRs. Higher
expression of SLPI in the visceral depots (mesenteric and
epididymal) than the subcutaneous correlates with
greater inflammation in the visceral depots than the sub-
cutaneous depot. Elevated SLPI in the visceral depots
could be part of the endogenous anti-inflammatory
response to counter localized inflammation in these
depots. Because visceral adiposity is linked to insulin
resistance, induction of SLPI locally in adipose may also
play a role in the prevention of inflammation-induced
insulin resistance. In summary, we have demonstrated
that obesity is accompanied by increased expression of
SLPI in adipose tissue where it may act to suppress local
inflammation.
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